PharmaMar (Spain)

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

Giovanni Germano, Roberta Frapolli, Cristina Belgiovine et al. · Cancer Cell · 2013 · 847 citations · Full text

Cancer Immunosurveillance, Drug Targeting, Immunology +7

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

George D. Demetri, Sant P. Chawla, Margaret von Mehren et al. · Journal of Clinical Oncology · 2009 · 524 citations · Full text

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

Federica Grosso, Robin L. Jones, George D. Demetri et al. · The Lancet Oncology · 2007 · 447 citations

Retrospective Study, Surgical Oncology, Medicine +6

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

José Trigo, Vivek Subbiah, Benjamin Besse et al. · The Lancet Oncology · 2020 · 433 citations

Second-line Treatment, Oncology, Metronomic Therapy +9

A comparison between two brine shrimp assays to detect in vitrocytotoxicity in marine natural products

José Luís Carballo, Zaira L Hernández-Inda, Pilar Pérez et al. · BMC Biotechnology · 2002 · 394 citations · Full text